We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+9%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$24.5B
AUM Growth
+$4.37B
Cap. Flow
+$2.47B
Cap. Flow %
10.08%
Top 10 Hldgs %
39.35%
Holding
397
New
164
Increased
36
Reduced
47
Closed
100

Top Buys

Rank Stock Value
1
NUAN
Nuance Communications, Inc.
NUAN
+$387M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$332M
3
NOW icon
ServiceNow
NOW
+$265M
4
NYT icon
New York Times
NYT
+$189M
5
MXIM
Maxim Integrated Products
MXIM
+$152M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$456M
2
IPHI
INPHI CORPORATION
IPHI
+$311M
3
IQV icon
IQVIA
IQV
+$278M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$277M
5
EDU icon
New Oriental
EDU
+$192M

Sector Composition

Rank Sector Weight
1 Healthcare 29.51%
2 Technology 16.43%
3 Financials 13.12%
4 Communication Services 9.43%
5 Industrials 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
76
Biogen
BIIB
$32B
$37.7M 0.15%
109,000
+6,000
+6% +$1.82M
TPTX
77
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$36.3M 0.15%
465,000
-35,000
-7% -$2.59M
QTRX icon
78
Quanterix
QTRX
$141M
$32M 0.13%
545,000
-55,000
-9% -$3.19M
EXAS
79
DELISTED
Exact Sciences
EXAS
$31.1M 0.13%
+250,000
New +$29.8M
ANNX icon
80
Annexon
ANNX
$961M
$30.6M 0.12%
1,358,107
-97,739
-7% -$2.17M
ARWR icon
81
Arrowhead Research
ARWR
$12.3B
$30.2M 0.12%
365,000
+192,546
+112% +$14.3M
TVRD
82
Tvardi Therapeutics
TVRD
$24.8M
$28.5M 0.12%
55,556
-12,916
-19% -$8.18M
KVSC
83
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
$27.8M 0.11%
2,809,000
– –
AJRD
84
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$26.3M 0.11%
+545,000
New +$26.2M
TLND
85
DELISTED
Talend S.A. American Depositary Shares
TLND
$24.9M 0.1%
+380,000
New +$24.6M
PNT
86
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$24.7M 0.1%
+2,400,000
New +$24.4M
CLVR
87
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$24.6M 0.1%
84,792
+8,856
+12% +$2.73M
NUVB icon
88
Nuvation Bio
NUVB
$2.43B
$23.3M 0.1%
2,498,600
-1,400
-0.1% -$16K
NXDR
89
Nextdoor Holdings
NXDR
$925M
$22.3M 0.09%
2,250,000
– –
QSI icon
90
Quantum-Si Incorporated
QSI
$183M
$21.5M 0.09%
+1,750,000
New +$18.3M
AUS
91
DELISTED
Austerlitz Acquisition Corporation I
AUS
$20.9M 0.09%
+2,109,700
New +$20.9M
DCRC
92
DELISTED
Decarbonization Plus Acquisition Corporation III Class A Common Stock
DCRC
$20.7M 0.08%
+2,000,000
New +$20.9M
RC
93
Ready Capital
RC
$311M
$19.8M 0.08%
1,250,226
– –
REVH
94
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
$19.6M 0.08%
+2,000,000
New +$19.7M
TGTX icon
95
TG Therapeutics
TGTX
$8.31B
$19.4M 0.08%
500,000
– –
NEO icon
96
NeoGenomics
NEO
$2.18B
$19M 0.08%
+420,000
New +$18.6M
FVIV
97
DELISTED
Fortress Value Acquisition Corp. IV
FVIV
$17.2M 0.07%
+1,750,000
New +$17.2M
SHQAU
98
DELISTED
Shelter Acquisition Corporation I Units
SHQAU
$16.5M 0.07%
+1,650,000
New +$16.5M
RCEL icon
99
Avita Medical
RCEL
$311M
$16.4M 0.07%
800,000
– –
IMA
100
ImageneBio Inc
IMA
$62.5M
$15.7M 0.06%
93,112
-19,347
-17% -$4.27M
2 3
4
5 6

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q2 2021 Portfolio in Review

As of Q2 2021, Thomas Steyer held 397 positions worth $24.5B, up 22% from $20.1B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Thomas Steyer deployed $2.47B of net new capital in Q2 2021, opening 164 new positions and adding to 36 existing holdings. Its largest new stake was Nuance Communications, Inc.: 7,337,500 shares worth $399M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 36% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $456M trimmed.

  • Thomas Steyer's largest Q2 2021 buy was Nuance Communications, Inc.: 7,337,500 shares worth $399M.
  • Thomas Steyer added most to Alexion Pharmaceuticals in Q2 2021, an estimated $332M increase.
  • Thomas Steyer's biggest Q2 2021 reduction was Alphabet (Google) Class C, cutting an estimated $456M.
  • Thomas Steyer fully exited INPHI CORPORATION in Q2 2021, selling an estimated $311M.
  • Thomas Steyer's ten largest holdings make up 39% of its $24.5B portfolio in Q2 2021.
  • Thomas Steyer opened 164 new positions and closed 100 in Q2 2021.
  • Thomas Steyer's portfolio value rose 22% quarter-over-quarter to $24.5B.

Based on Farallon Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.